# GAGE12J

## Overview
GAGE12J is a gene that encodes the G antigen 12J protein, which is part of the GAGE family of cancer-testis antigens. These antigens are typically expressed in a variety of tumors and are known for their restricted expression in normal tissues, primarily limited to the testis, making them attractive targets for cancer immunotherapy (Kalvapudi2024Cancertestis). The G antigen 12J protein is implicated in cancer-related processes, although its precise biological functions remain to be fully elucidated. Research has highlighted its expression in certain cancers, such as cutaneous angiosarcoma and pancreatic cancer, suggesting a potential role in tumorigenesis and cancer progression (Biel2023Transcriptomic; Magara2023Tumor). Despite its involvement in these malignancies, the specific mechanisms by which GAGE12J contributes to cancer biology are not yet well understood, necessitating further investigation to determine its utility as a therapeutic target or biomarker (Kalvapudi2024Cancertestis).

## Structure


## Clinical Significance
GAGE12J, a member of the GAGE family of cancer-testis antigens, is implicated in various cancer-related processes. Its expression is notably upregulated in recurrent lesions of cutaneous angiosarcoma, although the specific role of GAGE12J in this context remains unclear (Magara2023Tumor). In pancreatic cancer, GAGE12J was identified as having increased expression in tumors from Black patients, but this increase was not statistically significant, suggesting a potential but unconfirmed role in racial disparities in cancer expression profiles (Biel2023Transcriptomic). In gastroesophageal adenocarcinoma, GAGE12J was the least expressed gene among the cancer/testis antigens studied, indicating a limited role in this cancer type (Kalvapudi2024Cancertestis). The clinical significance of GAGE12J in these cancers is not fully understood, and further research is needed to elucidate its potential as a therapeutic target or prognostic marker. The GAGE family, including GAGE12J, is generally recognized for its immunogenic properties, making it a candidate for cancer immunotherapy, although specific clinical applications for GAGE12J have yet to be established (Kalvapudi2024Cancertestis).


## References


[1. (Biel2023Transcriptomic) Thomas G. Biel, Svetlana Petrovskaya, Francesca Mascia, Tongzhong Ju, Lola Fashoyin-Aje, Kelly M. Herremans, Andrea N. Riner, Patrick W. Underwood, Michael H. Gerber, Martha Donoghue, Jose G. Trevino, and V. Ashutosh Rao. Transcriptomic analysis of pancreatic adenocarcinoma specimens obtained from black and white patients. PLOS ONE, 18(2):e0281182, February 2023. URL: http://dx.doi.org/10.1371/journal.pone.0281182, doi:10.1371/journal.pone.0281182. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0281182)

[2. (Kalvapudi2024Cancertestis) Sukumar Kalvapudi, Akhil Goud Pachimatla, R. J. Seager, Jeffrey Conroy, Sarabjot Pabla, and Sarbajit Mukherjee. Cancer/testis antigen expression and co-expression patterns in gastroesophageal adenocarcinoma. Medical Oncology, August 2024. URL: http://dx.doi.org/10.1007/s12032-024-02475-6, doi:10.1007/s12032-024-02475-6. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s12032-024-02475-6)

[3. (Magara2023Tumor) Tetsuya Magara, Motoki Nakamura, Yuka Nojiri, Maki Yoshimitsu, Shinji Kano, Hiroshi Kato, and Akimichi Morita. Tumor immune microenvironment of cutaneous angiosarcoma with cancer testis antigens and the formation of tertiary lymphoid structures. Frontiers in Oncology, April 2023. URL: http://dx.doi.org/10.3389/fonc.2023.1106434, doi:10.3389/fonc.2023.1106434. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fonc.2023.1106434)